NASDAQ:LPCN

Lipocine Stock Predictions

Healthcare > Biotechnology

Buy LPCN

*Your capital is at risk

$2.12

+0.0100 (+0.474%)

At Close: Jul 31, 2026

Currently predicting for Mon, 3 Aug 2026

LPCN Live board

Community Bull/Bear

Target Next close

Join the LPCN prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

LPCN Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For LPCN

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

LPCN Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT LIPOCINE INC.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FOX $50.81	2.22%	Jul 27
UNFI $49.05	3.63%	Jul 27
BIIB $202.19	0.376%	Jul 24
TSCO $30.32	1.48%	Jul 23
S SW $43.71	5.17%	Jul 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by